Treatment benefit and treatment harm rate to characterize heterogeneity in treatment effect
From MaRDI portal
Recommendations
- Assessing the heterogeneity of treatment effects by identifying the treatment benefit rate and treatment harm rate
- Assessing the treatment effect heterogeneity with a latent variable
- Using secondary outcome to sharpen bounds for treatment harm rate in characterizing heterogeneity
- Identification of subpopulations with distinct treatment benefit rate using the Bayesian tree
- Estimating treatment effect heterogeneity for binary outcomes via Dirichlet multinomial constraints
Cites work
- Asymptotic Statistics
- Cox's regression model for counting processes: A large sample study
- Individual treatment effects in randomized trials with binary outcomes.
- Inference and missing data
- The product-limit estimator and the bootstrap: Some asymptotic representations
- Unit–Treatment Interaction and Its Practical Consequences
Cited in
(5)- Identification of subpopulations with distinct treatment benefit rate using the Bayesian tree
- Assessing the treatment effect heterogeneity with a latent variable
- Assessing the heterogeneity of treatment effects by identifying the treatment benefit rate and treatment harm rate
- Using secondary outcome to sharpen bounds for treatment harm rate in characterizing heterogeneity
- Semiparametric efficient inference for the probability of necessary and sufficient causation
This page was built for publication: Treatment benefit and treatment harm rate to characterize heterogeneity in treatment effect
Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q2861962)
